Let's celebrate International Biotechnology Day🧬 and its profound impact on health. At Oncoliq, we harness the power of science and machine learning to provide society with early cancer detection methods. We firmly believe that patients worldwide should have accurate and early information about their health🩸. With a team of biotechnology professionals, we are working towards a future where patients have more chances of surviving the disease and better treatments. Today, we celebrate the team that makes Oncoliq a promise for everyone!👩🔬👨🔬 #BiotechnologyDay #Oncoliq #EarlyCancerDetection
Oncoliq’s Post
More Relevant Posts
-
🔬Dive into the world of ATAC-Seq analysis with Genexplain Platform! Learn how to harness the power of the geneXplain #transfac platform for your research. Visit:https://lnkd.in/g8B_YgDD Key features of transfac: Interlinked reports, Enhancer reports, Site reports, Transcription factor reports, Transcription factor–site interactions, TFBS ChIP-seq reports, Positional weight matrices (PWMs), Promoter reports, Transcription factor binding sites, MATCH Suite – an integrated tool for TFBS search. #ATACSeq #geneXplain #Bioinformatics #DataScience #Genomics #sciencefacts #biomedicalresearch #clinicalresearch #cancer #MicroRNA #generegulation #transcriptionfactor #genomicscience #biotech #biotechnology_science
To view or add a comment, sign in
-
Organ-on-a-chip (OOC) models, cultivating human cells to mimic biology, are revolutionizing preclinical research. Unlike animal studies, OOC offers cost efficiency and human-relevant data. From COVID drug screening to modeling diseases like diabetes and cancer, OOC tech is a game-changer. Challenges persist in neurodegeneration modeling, but collaborative efforts and FDA support signal a shift. Are OOC models the future of preclinical research? Read more from The Medicine Maker: http://spkl.io/60464q7Aa #DrugDiscovery #Innovation #ResearchRevolution
To view or add a comment, sign in
-
⚡ The global patent landscape of artificial intelligence applications for cancer | Nature Discover more at "voltsbase.com/energy" #Energy #Voltsbase
To view or add a comment, sign in
-
Continuing our series on Cell Culture & Imaging Analysis, we spotlight SYNENTEC's innovative approach to observing dynamic protein translocations in crucial cancer cell lines: ▪ Using our proprietary YT-SOFTWARE®, we've developed an advanced tool for analysing protein translocation through immunofluorescence staining. ▪ Employing our automated imagers, NYONE® and CELLAVISTA®, we achieve high-resolution imaging critical for detailed analysis. ▪ Our series showcases translocation assays of key proteins, STAT3 and NF-κB, using this sophisticated software. ▪ This new methodology streamlines the process, bypassing complex traditional protocols and delivering rapid, precise results. #Science #Biotech #ProteinTrafficking #HighThroughputScreening #Innovation #Dynamicprotein #SYNENTEC #Inisghts #Cellculture #imaging #imaginganalysis
To view or add a comment, sign in
-
📣 Attention to all researchers from Immuno-Oncology 📣 You always wanted to analyse the interaction of #TCells and #cancer cells without using potentially toxic labels and fluorescence excitation? Then don´t miss our webinar on 19th September. 🗓 To register, follow this link: https://lnkd.in/ghNMTxrC The video below shows the screening of #bispecific #antibodies to test T-cell response. No fluorescence staining has been used, the colours represent different cell populations that have been segmented completely #labelfree. 🔬 Applications from Light Chain Bioscience | Novimmune SA, TRON-Mainz, dsm-firmenich and bit.bio will be shown during this webinar. Don´t miss it. ❕❕❕ #biotechnology #sciencecommunication #medtech #innovation #cellimaging #research #technology #nanolive
To view or add a comment, sign in
-
Bio-Techne, in collaboration with Luminex, co-authored a thought-provoking white paper underscoring the crucial role proteomics plays in advancing early cancer detection, as well as its ability to help researchers identify cancers earlier than methods that rely exclusively on genomics. See the October edition of our xMAP Resource Round-Up newsletter to read the white paper and learn more about the most exciting developments utilizing #xMAP Technology. #biotech #sciencenews #healthcare #healthscience Still not a subscriber? Sign up now for monthly xMAP updates and news delivered directly to your inbox: https://hubs.li/Q029d2pG0
To view or add a comment, sign in
-
Discover proper quality controls in biobanking to ensure your biospecimens are suitable for their intended use. In this short video clip from our free on-demand webinar, Katharina Krohn, Vice President Global Biobanks, helps explain the insights on the future of biobanking. Tailored for researchers looking to revolutionize their approach to human biospecimen collection and analysis, the full webinar is now on-demand. Katharina's comprehensive overview of cutting-edge techniques and technologies in biobanking, emphasizing their critical role in advancing medical research will help you enhance your studies. Be part of the community shaping the future of personalized medicine and beyond. Watch Now ➡️ https://bit.ly/4acAWx1 #Biobanking #Oncology #PersonalizedMedicine
To view or add a comment, sign in
-
Enjoy reading the new publication of a team of BioNukleo and the Chair of Bioprocess Engineering at Technische Universität Berlin on "Bioprocess development to produce a hyperthermostable S-methyl-5′-thioadenosine phosphorylases in Escherichia coli". 👉 https://lnkd.in/ed2TsuEA Nucleoside phosphorylases are important biocatalysts for the chemo-enzymatic synthesis of nucleosides and their analogs which are, among others, used for the treatment of viral infections or cancer. Authors: Julia Schollmeyer, Saskia Waldburger, Kendra Njo, Heba Yehia, PhD (Dr. rer. nat), Anke Kurreck, Peter Neubauer, and Sebastian L. Riedel #processdevelopment #nucleoside #phosphorylases #biocatalysis
To view or add a comment, sign in
-
Nice example of how high-quality data, coupled with fantastic tech and data science experts can expedite the extraction of insight within R&D.... great work Thom Pijnenburg for your part in this work #data #technology #datascience #insights
Coupling data with technology for business benefit (aka #digitaltransformation) works especially well when the right domain experts are in the room as evidenced by this case study. An AstraZeneca and an Elsevier team of #drugdiscovery and #datascience experts assembled a literature base and a powerful suite of computational tools to increase the efficiency and depth of target discovery in the #oncology #epigentics space. Learn more about their results here: https://lnkd.in/en-3pcUn Congrats and thanks to the team: Vishwa Nellore, Sophie Kirschner, Steven Criscione, Joshua Armenia, James Hadfield, Tom Plasterer, Krishna C Bulusu, Payal Mitra, Thom Pijnenburg, Tim Miller, Ted Slater
Using knowledge graphs to drive epigenetic target discovery in oncology with AstraZeneca
view.highspot.com
To view or add a comment, sign in
-
AI has been a game-changer in the field of cancer research and treatment. I'm thrilled to share that next week I’ll be engaging in a Fireside chat with Laura Chang, the editorial director at STAT, to discuss "AI and the Future of Cancer Care" at the upcoming STAT Breakthrough Summit East. The summit will kick off with an introduction by Matthew Herper. Join me in person or online to learn more about how AI is revolutionizing cancer care and engage in thought-provoking discussions on the future of healthcare. #cancerresearch #AI #STATsummit
2024 Breakthrough Summit East - STAT
https://www.statnews.com
To view or add a comment, sign in
3,350 followers
Viva la biotecnología y en especial, la hecha en Argentina ! A seguir creciendo